These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24443270)
41. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol. Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781 [TBL] [Abstract][Full Text] [Related]
42. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy. Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845 [TBL] [Abstract][Full Text] [Related]
43. Cationic polybutyl cyanoacrylate nanoparticles for DNA delivery. Duan J; Zhang Y; Chen W; Shen C; Liao M; Pan Y; Wang J; Deng X; Zhao J J Biomed Biotechnol; 2009; 2009():149254. PubMed ID: 19300519 [TBL] [Abstract][Full Text] [Related]
44. Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice. Xu N; Gu J; Zhu Y; Wen H; Ren Q; Chen J Int J Nanomedicine; 2011; 6():905-13. PubMed ID: 21720503 [TBL] [Abstract][Full Text] [Related]
45. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats. Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669 [TBL] [Abstract][Full Text] [Related]
46. Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells. Kumar A; Ahuja A; Ali J; Baboota S Drug Deliv; 2016; 23(1):214-29. PubMed ID: 24825490 [TBL] [Abstract][Full Text] [Related]
47. Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development. Maksimenko O; Malinovskaya J; Shipulo E; Osipova N; Razzhivina V; Arantseva D; Yarovaya O; Mostovaya U; Khalansky A; Fedoseeva V; Alekseeva A; Vanchugova L; Gorshkova M; Kovalenko E; Balabanyan V; Melnikov P; Baklaushev V; Chekhonin V; Kreuter J; Gelperina S Int J Pharm; 2019 Dec; 572():118733. PubMed ID: 31689481 [TBL] [Abstract][Full Text] [Related]
48. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Tian XH; Lin XN; Wei F; Feng W; Huang ZC; Wang P; Ren L; Diao Y Int J Nanomedicine; 2011; 6():445-52. PubMed ID: 21445277 [TBL] [Abstract][Full Text] [Related]
49. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. He M; Zhao Z; Yin L; Tang C; Yin C Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302 [TBL] [Abstract][Full Text] [Related]
50. [Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles]. Chen RD; Ren F; Li GF; Liu SJ Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):763-6. PubMed ID: 20423845 [TBL] [Abstract][Full Text] [Related]
51. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. Caban-Toktas S; Sahin A; Lule S; Esendagli G; Vural I; Karlı Oguz K; Soylemezoglu F; Mut M; Dalkara T; Khan M; Capan Y Int J Pharm; 2020 Mar; 578():119076. PubMed ID: 31988035 [TBL] [Abstract][Full Text] [Related]
52. Anticancer Effect of Cisplatin-Loaded Poly (Butylcyanoacrylate) Nanoparticles on A172 Brain Cancer Cells Line. Vaisi-Raygani A; Khazaei M; Bakhtiari M; Arkan E; Aghaz F Asian Pac J Cancer Prev; 2020 Feb; 21(2):273-274. PubMed ID: 32102498 [No Abstract] [Full Text] [Related]
53. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin. Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359 [TBL] [Abstract][Full Text] [Related]
54. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment. Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304 [TBL] [Abstract][Full Text] [Related]
55. Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1. Baklaushev VP; Nukolova NN; Khalansky AS; Gurina OI; Yusubalieva GM; Grinenko NP; Gubskiy IL; Melnikov PA; Kardashova KSh; Kabanov AV; Chekhonin VP Drug Deliv; 2015 May; 22(3):276-85. PubMed ID: 24437962 [TBL] [Abstract][Full Text] [Related]
56. Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems. Gao S; Xu Y; Asghar S; Chen M; Zou L; Eltayeb S; Huo M; Ping Q; Xiao Y J Drug Target; 2015; 23(6):481-96. PubMed ID: 25738991 [TBL] [Abstract][Full Text] [Related]
57. Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo. Kolter M; Ott M; Hauer C; Reimold I; Fricker G J Control Release; 2015 Jan; 197():165-79. PubMed ID: 25445700 [TBL] [Abstract][Full Text] [Related]
58. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Joshi SA; Chavhan SS; Sawant KK Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869 [TBL] [Abstract][Full Text] [Related]